The research is moving forward, and even the cautious editorial author, underscored the importance of further study.
I think there is some danger in latching on to the number 20%. The 95% confidence interval around that would range from 2.7% to 69.1%. And, since 2 of 5 people got worse (40%), the 95% confidence interval for harm is 10% to 80%. BUT, You need more people and some control of co-variates (i.e., severity, smoking history ... etc) to have good ideas about
% helped and % hurt.
study details said...
Two of the patients in this study had
ongoing and increasing elevation of their CRP compared with
the post-metronidazole baseline level, suggesting that they may
have become sicker aft er this treatment. In the follow-up phase,
the authors describe a “collapse” due to orthostasis and, separately,
an unexplained case of pancreatitis. These observations
reinforce that administering a large volume of bacteria foreign
to the recipient, especially in those with an impaired mucosal
integrity, may have unintended consequences.
I think people who suspect they may have undetected c.diff, or people with mild but prolonged symptoms, may want to try FT, provided they can put as many safeguards as possible in place. This describes me. I need to think about
this. First I want to do a trial going off 5-asa, just to make sure my residual symptoms are not from the meds. Also, I might wait for some type of FT pill. (But if I was given the option to have some donor FM during my next scoping, I would likely say yes.)
On the other hand, I think anybody that is just enamored of "natural" or just hates "Big Pharma" should seek help from a psychologist before seeking FMT, because 1 in 5 helped and 2 in 5 harmed is not good odds.